Nomura Holdings
WVE icon

Nomura Holdings’s Wave Life Sciences WVE Stock Holding History

Nomura Holdings’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,500
Closed -$121K – 2203
2025
Q3 		$121K Sell
16,500
-33,700
-67% -$273K ﹤0.01% 1802
2025
Q2 		$326K Buy
+50,200
New +$332K ﹤0.01% 1222

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Nomura Holdings's WVE Position: Q3 2025 in Review

Nomura Holdings sold out of Wave Life Sciences (WVE) in Q3 2025, closing a stake of 14,829 shares — an estimated $120K sold.

Nomura Holdings first reported a position in WVE in Q2 2024 and held it in 5 quarters. The position peaked at $186K in Q4 2024. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • Nomura Holdings reported no remaining Wave Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Nomura Holdings sold 14,829 Wave Life Sciences shares in Q3 2025, an estimated $120K.
  • Nomura Holdings first reported a position in Wave Life Sciences in Q2 2024 and held it in 5 quarters.
  • Nomura Holdings's Wave Life Sciences position peaked at $186K in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Nomura Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.